NCT01340469View on ClinicalTrials.gov

Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2008

Conditions

Nosocomial InfectionNecrotizing Enterocolitis

Interventions

BIOLOGICAL

probiotics

Daily enteral probiotic supplementation (live Lactobacillus acidophilus and Bifidobacterium infantis) at a dose of 2.5 x 108 CFU of each strain once a day.The supplementation was started on the first day of enteral feeding and continued for at least 28 days or until discharge. The study drug was in liquid form and mixed with breast milk or formula before given to the infants. The preparation was made on a daily basis by one person who was not involved in the care of the infants.

Trial Locations (1)

10330

Faculty of Medicine Chilalongkorn University, Bangkok

All Listed Sponsors

lead

King Chulalongkorn Memorial Hospital

OTHER

NCT01340469 - Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants | Biotech Hunter | Biotech Hunter